The global spatial genomics & transcriptomics market is projected to grow at a CAGR of 7%-9% during 2020-2025. The growth of spatial genomics & transcriptomics market is driven increasing prevalence of cancer, rising demand for biomarkers, and growing adoption of in situ sequencing techniques.
Some of the Key Questions answered in this exclusive report are:
Q.1 What are some of the
most promising, high-growth opportunities for the spatial genomics &
transcriptomics market by product (instruments (mode (automated,
semi-automated, and manual), type (sequencing platforms, IHC, microscopy, flow
cytometry, mass spectrometry, and others)), consumables, and software
(bioinformatics tools, imaging tools, and storage & management databases)),
technology (spatial transcriptomics (sequencing-based methods (LCM, TIVA, in
situ sequencing, and microtomy sequencing), IHC, and microscopy-based RNA
imaging techniques (smFISH, padlock probes/ rolling circle amplification, and
branched DNA probes)), spatial genomics (FISH, microscopy-based live DNA
imaging, genome perturbation tools, massively-parallel sequencing, biochemical
techniques, and others)), application (diagnostics & disease profiling,
drug discovery, and others), end use (translational research, academic
customers, diagnostic customers, and pharmaceutical manufacturer), and region
(North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will
grow at a faster pace and why?
Q.3 What are the
business risks and threats to the spatial genomics & transcriptomics market?
Q.4 What are some
changing demands of customers in the spatial genomics & transcriptomics market?
Q.5 What are the new
developments in the spatial genomics & transcriptomics market? Which
companies are leading these developments?
Q.6 What strategic
initiatives are being implemented by key players for business growth?
Q.7 What are some of the
competitive products and processes in this spatial genomics &
transcriptomics area and how big of a threat do they pose for loss of market
share via product substitution?
Q.8 What M&A
activity has occurred in the last 5 years in this spatial genomics &
transcriptomics market?
Download Brochure of this report by clicking on https://www.lucintel.com/spatial-genomics-aand-transcriptomics-market.aspx
Market Segmentation:
Based on product, the
spatial genomics & transcriptomics market is segmented into instruments
(mode (automated, semi-automated, and manual), type (sequencing platforms, IHC,
microscopy, flow cytometry, mass spectrometry, and others)), consumables, and
software (bioinformatics tools, imaging tools, and storage & management
databases)). The consumables segment accounted for the largest share of the
market in 2020 due to increasing prevalence of cancer and increasing research
and development activities related to genomics.
North America is
expected to be the largest region over the forecast period over the forecast
period due to rising cancer research activities and increasing focus on genomic
based research and development in the region.
Key Players in the spatial
genomics & transcriptomics market are 10x Genomics, Dovetail Genomics,
Illumina,S2 Genomics, NanoString Technologies, Seven Bridges Genomics, Horizon
Discovery Group, CARTANA, Advanced Cell Diagnostics, and Spatial
Transcriptomics.
Request Sample Pages by clicking on https://www.lucintel.com/spatial-genomics-aand-transcriptomics-market.aspx
The
report helps stakeholders understand the pulse of the market and provides them
with information on key drivers, restraints, challenges, and opportunities for
market growth. It would also help to understand the competitors better and gain
more insights to improve their position in the business.
To read more about this market please click on
https://www.lucintel.com/spatial-genomics-aand-transcriptomics-market.aspx
About
Lucintel
Lucintel,
the premier global management consulting and market research firm, creates
winning strategies for growth. It offers market assessments, competitive
analysis, opportunity
analysis, growth
consulting, M&A, and due diligence services to executives and
key decision-makers in a variety of industries. For further information, visit www.lucintel.com.
Brandon
Fitzgerald
Lucintel
Dallas,
Texas, USA
Email: brandon.fitzgerald@lucintel.com
Tel. 972.636.5056
Cell: 303.775.0751
Related reports
Minimally
Invasive Surgical Instrument Market:
For more details click here https://www.lucintel.com/minimally-invasive-surgical-instrument-market.aspx
Endoscopy
Equipment Market:
For more details click here https://www.lucintel.com/endoscopy-equipment-market.aspx
Surgical Instrument Tracking System Market:
For more details click here https://www.lucintel.com/surgical-instrument-tracking-system-market.aspx
Metabolomics Market:
For more details click here https://www.lucintel.com/metabolomics-market.aspx
Industrial Microbiology Market:
For more details click here https://www.lucintel.com/industrial-microbiology-market.aspx
Surgical Microscope Market:
For more details click here https://www.lucintel.com/surgical-microscope-market.aspx
Tumor
Ablation Market:
For more details click here https://www.lucintel.com/tumor-ablation-market.aspx
Vitamin D Market:
For more details click here https://www.lucintel.com/vitamin-d-market.aspx
Urology
Device Market:
For more details click here https://www.lucintel.com/urology-device-market.aspx
Gene Expression Market:
For more details click here https://www.lucintel.com/gene-expression-market.aspx
No comments:
Post a Comment